Vera Therapeutics Presents New Analysis of Phase 2a JANUS
New analysis of Phase 2a JANUS clinical trial showed atacicept reduced immune complex levels in patients with IgA nephropathy (IgAN)Atacicept is the first...
Source: globenewswire.com
📰 Randomized Phase News
Page 7 - Randomized Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Randomized Phase. Real-time updates on events, politics, business and more.
Legend Biotech Shares Updated Data from Comprehensive Cilta-Cel Clinical Development Program at ASH
Seven accepted poster presentations showcase our continued leadership in CAR-T cell therapy research for patients with multiple myelomaNew analysis of sustained minimal residual disease (MRD) negativity from the pivotal CARTITUDE-1 study of CARVYKTI® (ciltacabtagene autoleucel, cilta-cel) in heavily pretreated adult...
United States Hemophagocytic Lymphohistiocytosis Ciltacabtagene Autoleucel Joanne Choi Ying Huang Biotech Corporation
Source: pharmiweb.com
More than 50 Abstracts from Incyte's Robust Oncology Portfolio to be Featured at the 64th ASH Annual Meeting
- Plenary Scientific Session to highlight Incyte-discovered novel anti-mutant CALR-targeted monoclonal antibody INCA033989 - Data from three of the Company's LIMBER studies evaluating ruxolitinib
United States United Kingdom Catalina Loveman Ponatinib Iclusig Peter Langmuir Bendamustine Rituximab
Source: finanznachrichten.de
Bausch Health Companies Inc: Ortho Dermatologics to Present New Data at the 2022 Innovations in Dermatology Conference
Nine Poster Presentations Include New Analyses of SILIQ® and JUBLIA®LAVAL, QC / ACCESSWIRE / November 1, 2022 / - Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its dermatology
Source: finanznachrichten.de
Atossa Therapeutics, Inc. Receives Authorization from FDA
Atossa to begin Phase 2 Study of (Z)-endoxifen in 4th Quarter...
United States Matthew Goetz Kyle Guse Exchange Commission Atossa Therapeutics Inc Contract Research Organization
Source: globenewswire.com
AbbVie to Present Data from Extensive Portfolio at American College of Gastroenterology Annual Scientific Meeting
Data illustrates AbbVies commitment to providing research and innovative solutions that support patients with high disease burden and unmet needOral presentations address treatment of moderate to severe Crohns disease, including
United States Puerto Rico Celine Goldberger Boehringer Ingelheim Ironwood Pharmaceuticals Allergan United States Inc
Source: wsiltv.com
Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN's Kidney Week 2022
/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...
United States Orange County Convention Center Fosun Pharma Prnewswire Ardelyx Inc American Society Of Nephrology Kyowa Kirin Co Ltd
Source: prnewswire.com
Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN's Kidney Week 2022
WALTHAM, Mass., Oct. 20, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develo...
United States Orange County Convention Center Fosun Pharma Prnewswire Ardelyx Inc American Society Of Nephrology Kyowa Kirin Co Ltd
Source: businessinsider.com
Vera Therapeutics to Present Final Phase 2 Results of
BRISBANE, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and...
United States Orange County Convention Center Los Angeles Kathy Vincent Joyce Allaire Jonathan Barratt
Source: globenewswire.com
Vera Therapeutics to Present Final Phase 2 Results of MAU868 in Kidney Transplant Recipients with Reactivated BK Virus Infection and New Analysis of Phase 2a JANUS Trial of Atacicept in IgA Nephropathy at the American Society of Nephrology Kidney Week 2022 Annual Meeting
BRISBANE, Calif., Oct. 17, 2022 -- Vera Therapeutics, Inc. , a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious... | October 17, 2022
United States Orange County Convention Center Los Angeles Joyce Allaire Jonathan Barratt University Of Leicester
Source: marketscreener.com